Summer School Webinar Series (2020)
Summer School Webinar Series
We know urology HCP's today need quality education that works with your schedule- that's why the AUA has created our Summer School Webinar Series.
The AUA Summer School Webinar Series is the perfect way for urology healthcare professionals who find themselves with unpredictable schedules and travel restrictions to find opportunities for continuing education.
This series of over two dozen 90-minute live webinars will be offered twice per week, each week from May 26 through September 4. The Series covers a wide variety of topics, including BPH, stone disease, female urology, and genitourinary cancers including prostate cancer. The speakers and course directors are thought leaders presenting the high-quality educational content you expect.
We are pleased to offer all of these activities FREE to AUA Members - a significant member benefit. If you're not currently an AUA member and would like to join, please do and unlock your member benefits.
Surgical and Medical Management of Stones Guidelines Update: A Case-Based Approach
Course Director: Ojas Shah, MD
Course Faculty: Brian R. Matlaga, MD, MPH; Dean George Assimos, MD; John Charles Lieske, MD
Interstitial Cystitis/Bladder Pain Syndrome: Current Diagnosis and Management—Future Trends
Course Director: Philip M. Hanno, MD
Course Faculty: Quentin Clemens, MD; Sandor Lovasz, MD, PhD
Recurrent UTIs in Women: Ask the Guideline
Course Director: Jennifer T. Anger, MD
Course Faculty: Toby C. Chai, MD; Ann E. Stapleton, MD; Una Jeanie Lee, MD
Urodynamics – Indications & Interpretation: A Case-Based Approach
Wednesday, June 10 -8 pm EST
Course Director: Craig Vance Comiter, MD
Current Urologic Management of Female Sexual Dysfunction
Thursday, June 11 -7 pm EST
Course Director: Irwin Goldstein, MD
Course Faculty: Noel Noyull Kim, PhD; Rachel S. Rubin, MD; Ashley G. Winter, MD
AUA 2020 Guideline: Disorders of Ejaculation
Wednesday, June 17 -6 pm EST
Course Director: Alan William Shindel, MD
Course Faculty: Serge Carrier, MD; David Rowland, MD
What General Urologists Can Do To Comprehensively Evaluate & Successfully Treat Male Infertility
Thursday, June 18 - 1 pm EST
Course Director: Marc Goldstein, MD
Course Faculty: Peter Chan, MD; Mark Sigman, MD
Testis Cancer: Current Concepts & Controversies
Tuesday, June 23 - 12 pm EST
Course Director: Joel Sheinfeld, MD
Course Faculty: Brett S. Carver, MD; Darren Feldman, MD
Understanding the Evidence: New Technologies for Treating BPH and LUTS
Wednesday, June 24 -5 pm EST
Course Director: Peter J. Gilling, MD
Course Faculty: Dean Sol Elterman, MD, MSc, FRCSC; Henry Hyunshik Woo, MD; Michael S. Borofsky, MD
AUA 2020 Guideline: Advanced Prostate Cancer
Tuesday, June 30 -10 am EST
Course Director: Michael S. Cookson, MD, MMHC
Course Faculty: Adam S. Kibel, MD; David F. Jarrard, MD; William Thomas Lowrance, MD
Contemporary Pharmacotherapy for OAB 2020: Monotherapy and Combined Pharmacotherapy to Optimize Treatment
Thursday, July 2 - 7 pm EST
Course Director: Eric Scott Rovner, MD
Course Faculty: Christopher R. Chapple, MD; Alan J. Wein, MD, PhD
Controversies in Surgical Stone Management: A Case-Based Instructional Course
Tuesday, July 7 - 10 am EST
Course Director: Stephen Y. Nakada, MD
Course Faculty: Margaret Pearle, MD
Case-Based Discussion of AUA Non-muscle Invasive Bladder Cancer Guidelines
Wednesday, July 8 - 5 pm EST
Course Director: Sam S. Chang, MD
Course Faculty: Christopher Anderson, MD; James Michael McKiernan, MD; Chad R. Ritch, MD; Kristen R. Scarpato, MD
Trimodality Therapy for Management of Muscle Invasive Bladder Cancer
Tuesday, July 14 - 7 am EST
Course Director: Adam S. Feldman, MD, MPH
Course Faculty: Jason Efstathiou, MD, PhD; Richard J. Lee, MD, PhD
Diagnosis and Management of Localized, Locally Advanced and Advanced Kidney Cancer
Thursday, July 16 - 1 pm EST
Course Director: W. Marston Linehan, MD
Course Faculty: Mark W. Ball, MD; Ramaprasad Srinivasan, MD, PhD; David F. McDermott, MD
Chemotherapy and Immunotherapy for Genitourinary Malignancies: A Primer for Urologists and Advanced Practice Providers
Tuesday, July 21 - 1:30 pm EST
Course Director: Costas D. Lallas, MD
Course Faculty: Anne E. Calvaresi, NP; Edouard J. Trabulsi, MD
Refractory OAB: Tips and Tricks on Optimal 3rd Line Therapy Delivery
Thursday, July 23 - 8:30 pm EST
Course Director: Kathleen Chizuko Kobashi, MD
Course Faculty: Sandip Prasan Vasavada, MD; David Alan Ginsberg, MD
Management of NMIBC: Practical Solutions for Common Problems
Thursday, July 30 - 10:30 am EST
Course Director: Kamal S. Pohar, MD
Course Faculty: Cheryl Lee, MD, FACS; Fred Witjes, MD, PhD and Ashish Kamat, MD, MBBS, FACS
Using Shared Decision Making to Help Patients Decide on Prostate Cancer Screening and Treatment
Wednesday, August 5 - 9 am EST
Course Director: Danil Victor Makarov, MD, MHS
Course Faculty: Michael John Barry, MD
AUA Guidelines: Evaluation and Management of Localized Renal Masses: A Case-Based Approach
Thursday, August 6 - 6 pm EST
Course Director: Steven Charles Campbell, MD, PHD
Course Faculty: Brian Robert Lane, MD, PhD; Phillip M. Pierorazio, MD; Robert G. Uzzo, MD, MBA
Prostate Cancer Update 2020
Tuesday, August 11 - 3 pm EST
Course Director: William Catalona, MD
Course Faculty: Douglas Middleton Dahl, MD; Stanley Liauw, MD; Stacy Loeb, MD, PhD, MSc; Robert Brewster Nadler, MD; Russell Szmulewitz, MD
2020 Guideline: BPH
Thursday, August 13 - 6 pm EST
Course Director: Steven Abraham Kaplan, MD
Course Faculty: Kevin Thomas McVary, MD; J. Kellogg Parsons, MD, MHS; Claus Georg Roehrborn, MD; Alexis Edwin Te, MD
Urolithiasis: Metabolic Evaluation & Medical Treatment
Tuesday, August 18 - 7 pm EST
Course Director: Michael Eric Lipkin, MD
Course Faculty: Brian Howard Eisner, MD; Sara Lynn Best, MD; Jodi Antonelli, MD
Genetic Testing in Prostate Cancer: Considerations for Urologists and Their Patients
Thursday, August 20 - 2:30 pm EST
Course Director: Todd M. Morgan, MD
Course Faculty: Matthew R. Cooperberg, MD, MPH, Veda Giri, MD, Daniel W. Lin, MD
What's New in the Management of Hormone Naïve & Castrate Resistant Prostate Cancer: A Case-based Session for Urologists, Advanced Practice Providers & Teams
Tuesday, August 25 - 6 pm EST
Course Director: Judd W. Moul, MD, FACS
Course Faculty: Lawrence I. Karsh, MD, Evan Y. Yu, MD
Common Dilemmas in Prostate Cancer Detection and Management
Wednesday, August 26 - 10:30 am EST
Course Director: Gerald L. Andriole, Jr., MD
Course Faculty: Anthony Victor D'Amico, MD, PhD; Adam S. Kibel, MD; A. Oliver Sartor, MD
Integrating Care for Oncology Patients: Establishing a Multidisciplinary Oncology Clinic with Advanced Therapeutics
Tuesday, September 1 - 7 pm EST
Course Director: Kelly L. Stratton, MD
Course Faculty: Kelvin A. Moses, MD, PhD; Alicia Morgans, MD, MPH; Brian Matthew Shuch, MD
Renal Cell Carcinoma: Surgical & Medical Management of High-Risk Renal Cell Carcinoma: New Paradigms for Treatment
Wednesday, September 2 - 5 pm EST
Course Director: Benjamin R. Lee, MD
Course Faculty: A. Oliver Sartor, MD; Chandru P. Sundaram, MD, FACS, FRCS
- Advanced Practice Providers (Nurse Practitioners and Physician Assistants)
Each webinar has its own learning objectives. To see the learning objectives per webinar, click on the REGISTER tab and then click into each webinar listing. This will show course descriptions and learning objectives for the individual webinars.
See individual Summer School webinar listings for scientific agendas.
The AUA Summer School Webinar Series will be held virtually twice per week each week between May 26 and September 4.
To join your webinar:
- Click the "Register" tab.
- Click on the title of the webinar you wish to attend (prior registration required)
- If prompted, click “update your profile”. Otherwise, click “Take Course”.
- Click “Start” under Live Webinar in the Course Progress pane.
- Click "Join Webinar".
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Urological Association designates this live activity for a maximum of 43.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
EVIDENCE BASED CONTENT:
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA DISCLOSURE POLICY:
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST:
All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group for identification of conflicts of interest. The AUA COI Review Work Group, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or AUA COI Review Work Group.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:
The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
AUA Participant Information and Policies
The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
AUDIO, VIDEO AND PHOTOGRAPHIC EQUIPMENT:
The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meetings.
Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.
SPECIAL ASSISTANCE/DIETARY NEEDS:
The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.